Utilizing assays that assess specific T-cell-mediated immunity against cytomegalovirus
(CMV) holds the potential to enhance personalized strategies aimed at preventing and …

Novel strategies are needed to further reduce the burden of cytomegalovirus (CMV) disease
in solid-organ transplant (SOT) recipients. Measurement of the specific cell-mediated …

Cytomegalovirus (CMV) is one of the most common infections after solid organ
transplantation. Improved assays to predict viral replication and disease would help refine …

Cytomegalovirus (CMV) is one of the most important viral complications after solid organ
transplantation (SOT). Current preventive and management strategies rely primarily on …

The impact of CMV infection and disease in solid organ transplant (SOT) recipients
continues despite remarkable improvements in its prevention and management with antiviral …

Cell-mediated immune responses predict clinical cytomegalovirus (CMV) events but have
not been adopted into routine practice due to lack of interventional studies. Our objective …

Cytomegalovirus (CMV) is one of the most important opportunistic infections in solid organ
transplant (SOT) recipients. However, current techniques used to predict risk for CMV …

Abstract Purpose of Review Immune monitoring to determine when and how the recovery of
cytomegalovirus (CMV)-specific T-cells occurs post-transplantation may help clinicians to …

Background. Cytomegalovirus (CMV) disease remains an important problem in solid-organ
transplant recipients, with the greatest risk among donor CMV-seropositive, recipient …

Late-onset cytomegalovirus (CMV) disease commonly occurs after discontinuation of
antiviral prophylaxis. We determined the utility of testing CD8+ T-cell response against CMV …